Gene · 6523
Papers3,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A randomized double-blind phase Ib clinical trial of SY-009 in patients with type 2 diabetes mellitus. | Eur J Pharm Sci | 2024 | 37981049 | PubTator, text mining | PubMed |
| From Fish Physiology to Human Disease: The Discovery of the NCC, NKCC2, and the Cation-Coupled Chloride Cotransporters. | Kidney360 | 2024 | 37968800 | PubTator, text mining | PubMed |
| Role of Glycosuria in SGLT2 Inhibitor-Induced Cardiorenal Protection: A Mechanistic Analysis of the CREDENCE Trial. | Diabetes | 2024 | 37939214 | PubTator, text mining | PubMed |
| Identification of novel small molecule inhibitors for solute carrier SGLT1; a computational exploration. | J Biomol Struct Dyn | 2024 | 37855364 | PubTator, text mining | PubMed |
| SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus. | Curr Med Chem | 2024 | 37855338 | PubTator, text mining | PubMed |
Racial, ethnic and regional differences in the effect of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes: a systematic review and meta-analysis of cardiovascular outcome trials. | J R Soc Med | 2024 | 37734450 | PubTator, text mining | PubMed |
| SGLT2 and SGLT1 inhibitors suppress the activities of the RVLM neurons in newborn Wistar rats. | Hypertens Res | 2024 | 37710035 | PubTator, text mining | PubMed |
| AMPK-mediated autophagy is involved in the protective effect of canagliflozin in the vitamin D3 plus nicotine calcification model in rats. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 37522915 | PubTator, text mining | PubMed |
| Dual SGLT1 and SGLT2 inhibitor sotagliflozin achieves FDA approval: landmark or landmine? | Nat Cardiovasc Res | 2023 | 39195959 | PubTator, text mining | PubMed |
| SGLT2 inhibitors, intrarenal hypoxia and the diabetic kidney: insights into pathophysiological concepts and current evidence. | Arch Med Sci Atheroscler Dis | 2023 | 38283924 | PubTator, text mining | PubMed |
| The Effects of Artificial Sweeteners on Intestinal Nutrient-Sensing Receptors: Dr. Jekyll or Mr. Hyde? | Life (Basel) | 2023 | 38276259 | PubTator, text mining | PubMed |
| Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity? | J Pers Med | 2023 | 38248751 | PubTator, text mining | PubMed |
| A Prunus avium L. Infusion Inhibits Sugar Uptake and Counteracts Oxidative Stress-Induced Stimulation of Glucose Uptake by Intestinal Epithelial (Caco-2) Cells. | Antioxidants (Basel) | 2023 | 38247483 | PubTator, text mining | PubMed |
| Comparison of SGLT1, SGLT2, and Dual Inhibitor biological activity in treating Type 2 Diabetes Mellitus. | Adv Ther (Weinh) | 2023 | 38223846 | PubTator, text mining | PubMed |
| Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK/PGC-1α and inhibiting the RhoA/ROCK pathway. | World J Diabetes | 2023 | 38222788 | PubTator, text mining | PubMed |
| Resources for Human Health from the Plant Kingdom: The Potential Role of the Flavonoid Apigenin in Cancer Counteraction. | Int J Mol Sci | 2023 | 38203418 | PubTator, text mining | PubMed |
| Compositional Aspects of Beverages Designed to Promote Hydration Before, During, and After Exercise: Concepts Revisited. | Nutrients | 2023 | 38201848 | PubTator, text mining | PubMed |
| Is Environmental Cadmium Exposure Causally Related to Diabetes and Obesity? | Cells | 2023 | 38201287 | PubTator, text mining | PubMed |
| The metaproteome of the gut microbiota in pediatric patients affected by COVID-19. | Front Cell Infect Microbiol | 2023 | 38188629 | PubTator, text mining | PubMed |
| Comparative cardiovascular benefits of individual SGLT2 inhibitors in type 2 diabetes and heart failure: a systematic review and network meta-analysis of randomized controlled trials. | Front Endocrinol (Lausanne) | 2023 | 38179304 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6523/papers?page=13